Press Release: Transluminal Technologies receives CE Mark approval for velox CD vascular closure device
Transluminal Tech lands E.U. win for bioabsorbable vascular closure
Transluminal Technologies is ready to take on the European market with CE Mark approval for its flagship Velox CD vascular closure devices.
EndoShape raises $6.8M for vascular plugs and coils
EndoShape is in the process of raising $6.8 million in the latest reported funding round for the minimally invasive vessel occlusion devices maker.
Cardinal Health closes $320M AccessClosure buy
Cardinal Health (NYSE:CAH) said today that it closed its $320 million all-cash acquisition of AccessClosure and its Mynx extravascular closure technology.
The Mynx biodegradable sealant products are designed to close off the femoral artery and then dissolve within 30 days.
Admedus gains U.S. clearance for cardiovascular scaffold
Admedus won 510(k) clearance from the U.S. FDA for its CardioCel cardiovascular scaffold.
Perth, Australia and Minneapolis, Minn.-based Admedus is developing implantable regenerative technologies. CardioCel, the company’s 1st product, is a pure collagen, bio-compatible regenerative tissue scaffold.
Sapheon wins Canadian approval for medical adhesive
Sapheon secured approval from Health Canada for its VenaSeal Sapheon closure system, used in the treatment of varicose veins.
Morrisville, N.C.-based Sapheon develops treatments for vascular disease, its flagship product being the VenaSeal, a medical adhesive which seals blood vessels using a special glue. The company is currently working towards getting pre-market approval from the U.S. FDA.
Federal court rejects St. Jude’s appeal in infringement case against AccessClosure
Medtech titan St. Jude Medical’s (NYSE:STJ) lost a bid to appeal its lawsuit against AccessClosure after a federal court refused to hear a patent infringement claim over artery closure devices.
Scion Biomedical sues board member for trade secret theft
Scion Biomedical sued board member and interim chief strategy and operating officer Allison London Brown, accusing her of poaching trade secrets for her startup medical device company, Aegis Women’s Health Technologies.
Vascular Solutions settles Terumo patent infringement beef for $812k
Appeals court reverses St. Jude Medical win over Access Closure
FDA OKs Cardiva Medical’s Vascade vascular closure system
California medical device company Cardiva Medical won FDA approval for its Vascade extravascular closure device, the company announced this week.
The premarket approval was granted based on evidence from Cardiva’s 420-patient clinical trial, which demonstrated that Vascade beat the gold standard of manual compression for vascular closure patients undergoing percutaneous procedures via the femoral artery, according to a press release.
MassDevice Network
@MassDevice
LinkedIn
YouTube